Literature DB >> 17255846

Infliximab in pediatric Crohn disease patients with enterovesicular fistulas.

Jonathan E Teitelbaum1, Shehzad Saeed, Maria Triantafyllopoulou, Frederic Daum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255846     DOI: 10.1097/01.mpg.0000237933.38223.da

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  7 in total

1.  MR enterography of ileocolovesicular fistula in pediatric Crohn disease.

Authors:  Michelle D Sakala; Jonathan R Dillman; Maria F Ladino-Torres; Jonathan B McHugh; Jeremy Adler
Journal:  Pediatr Radiol       Date:  2010-11-13

Review 2.  Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Authors:  Parambir S Dulai; Corey A Siegel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

Review 3.  Infliximab therapy in children and adolescents with inflammatory bowel disease.

Authors:  Gabor Veres; Robert N Baldassano; Petar Mamula
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Use of the star sign to diagnose internal fistulas in pediatric patients with penetrating Crohn disease by MR enterography.

Authors:  Kiery A Braithwaite; Adina L Alazraki
Journal:  Pediatr Radiol       Date:  2014-02-18

5.  Crohn's disease presenting as enterovesical fistula.

Authors:  Paul Cullis; Dhanya Mullassery; Colin Baillie; Harriet Corbett
Journal:  BMJ Case Rep       Date:  2013-11-18

6.  Perforated diverticulitis in the setting of ulcerative colitis: An unusual case report.

Authors:  M Baimas-George; L Cetrulo; A Kao; K R Kasten
Journal:  Int J Surg Case Rep       Date:  2018-07-03

7.  Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2.

Authors:  Frank M Ruemmele; Joel Rosh; William A Faubion; Marla C Dubinsky; Dan Turner; Andreas Lazar; Samantha Eichner; Jen-Fue Maa; Gabriela Alperovich; Anne M Robinson; Jeffrey S Hyams
Journal:  J Crohns Colitis       Date:  2018-11-09       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.